Table 3.
Input | Mean | Sources |
---|---|---|
Annual rate of mSASSS change for mSASSS ≥10 | 1.440 | Corbett et al (2014)28 |
BASFI change associated with 1 unit change in mSASSS | 0.057 | Corbett et al (2014)28 |
Biologic treatment effect on progression for comparators | 0.420 | Corbett et al (2014)28 |
Biologic treatment effect on progression for secukinumaba | 0.153 | Calculated from MEASURE 1 trial data and using overall background progress rate from Ramiro et al (2015)50 |
Time to treatment effect (years) | 0 | Assumption |
Notes: The long-term changes in BASFI were assessed by progression of radiographic disease measured by mSASSS score.
This figure was calculated using the overall background progression rate of 0.98 units/year from the study by Ramiro et al (2015)50 and the MEASURE 1 week 104 mSASSS progression figure of 0.3.
Abbreviations: BASFI, Bath Ankylosing Spondylitis Functional Index; mSASSS, modified Stoke Ankylosing Spondylitis Spine Score.